Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Usefulness of DDAVP and GHRP-2 tests in patients with Cushing's disease
jRCTs021180039Recruiting
- Start
- May 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of desmopressin and KP102 in Corticotropin adenoma (ACTHoma). Primary endpoints: Serum ACTH response after DDAVP or GHRP-2 administration and Serum cortisol response after DDAVP or GHRP-2 administration. Started May 2018; status: recruiting.
02
Drugs
desmopressinKP102
03
Conditions
Corticotropin adenoma (ACTHoma)
Beyond the preview
Go deeper on jRCTs021180039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180039.